Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ruzicka

Showing results (271-280 of 564) with videos related to

Pageof 57
Sort By:
Clinical and Experimental Dermatology|November 29, 2005
Kissing café-au-lait macule of the eyelids: report of the first caseC Talhari, M Bylaite, H Plettenberg, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 27, 2003
[Mycophenolate mofetil as effective therapy option in scarring pemphigoid]I Elser, D Selimovic, T Ruzicka, et al.
The Journal of Investigative Dermatology|June 9, 2000
Neurotrophin-4 production by human epidermal keratinocytes: increased expression in atopic dermatitisM Grewe, K Vogelsang, T Ruzicka, et al.
Praxis|March 21, 2001
[Adjuvant therapy of malignant melanoma]W Franke, N J Neumann, T Ruzicka, et al.
Melanoma Research|February 24, 2001
Plantar malignant melanoma -- a challenge for early recognitionW Franke, N J Neumann, T Ruzicka, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 3, 2013
Ex vivo high-definition optical coherence tomography of basal cell carcinoma compared to frozen-section histology in micrographic surgery: a pilot studyT Maier, D Kulichová, T Ruzicka, et al.
Acta Dermato-Venereologica|January 1, 1988
Polymorphous light eruption: eliciting and inhibiting wavelengthsB Przybilla, A Galosi, M Heppeler, et al.
The British Journal of Dermatology|August 14, 2009
Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinraM Brenner, T Ruzicka, G Plewig, et al.
Skin Pharmacology and Applied Skin Physiology|May 27, 1999
Photodynamic diagnosis and therapy in dermatologyC Fritsch, K Lang, W Neuse, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1993
The lipoxygenase inhibitor 2-phenylmethyl-1-naphthol (DuP 654) is a 12(S)-hydroxyeicosatetraenoic acid receptor antagonist in the human epidermal cell line SCL-IIP Arenberger, A Raap, B Armah, et al.
Pageof 57

Showing results (271-280 of 564) with videos related to

Sort By:
Pageof 57
Clinical and Experimental Dermatology|November 29, 2005
Kissing café-au-lait macule of the eyelids: report of the first caseC Talhari, M Bylaite, H Plettenberg, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 27, 2003
[Mycophenolate mofetil as effective therapy option in scarring pemphigoid]I Elser, D Selimovic, T Ruzicka, et al.
The Journal of Investigative Dermatology|June 9, 2000
Neurotrophin-4 production by human epidermal keratinocytes: increased expression in atopic dermatitisM Grewe, K Vogelsang, T Ruzicka, et al.
Praxis|March 21, 2001
[Adjuvant therapy of malignant melanoma]W Franke, N J Neumann, T Ruzicka, et al.
Melanoma Research|February 24, 2001
Plantar malignant melanoma -- a challenge for early recognitionW Franke, N J Neumann, T Ruzicka, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 3, 2013
Ex vivo high-definition optical coherence tomography of basal cell carcinoma compared to frozen-section histology in micrographic surgery: a pilot studyT Maier, D Kulichová, T Ruzicka, et al.
Acta Dermato-Venereologica|January 1, 1988
Polymorphous light eruption: eliciting and inhibiting wavelengthsB Przybilla, A Galosi, M Heppeler, et al.
The British Journal of Dermatology|August 14, 2009
Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinraM Brenner, T Ruzicka, G Plewig, et al.
Skin Pharmacology and Applied Skin Physiology|May 27, 1999
Photodynamic diagnosis and therapy in dermatologyC Fritsch, K Lang, W Neuse, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1993
The lipoxygenase inhibitor 2-phenylmethyl-1-naphthol (DuP 654) is a 12(S)-hydroxyeicosatetraenoic acid receptor antagonist in the human epidermal cell line SCL-IIP Arenberger, A Raap, B Armah, et al.
Pageof 57